Skip to main content

BMJ Journals

  • Subscribe
  • Log In More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • Basket
  • Search More
    Advanced search
International Journal of Gynecologic Cancer
  • Latest content
  • Current issue
  • Archive
  • Authors
  • About

Advanced search

  • Close More

    Main menu

    • Latest content
    • Current issue
    • Archive
    • Authors
    • About
  • Subscribe
  • Log in More
    Log in via Institution
    Log in via OpenAthens

    Log in using your username and password

    For personal accounts OR managers of institutional accounts
    Forgot your log in details?Register a new account?
    Forgot your user name or password?
  • BMJ Journals

You are here

  • Home
  • Table of contents
  • Table of contents
Email alerts

Table of contents

Prev issue
Next issue

April 2005 - Volume 15 - Suppl 1

  • INTRODUCTION
  • ARTICLES

INTRODUCTION

  • Introduction to the Pre–International Gynecologic Cancer Society Roundtable Meeting: successful management of ovarian cancer (1 April, 2005)
    Andreas du Bois, Robert Ozols

ARTICLES

  • Treatment goals in ovarian cancer (1 April, 2005)
    R. F. Ozols
  • Gemcitabine monotherapy in recurrent ovarian cancer: from the bench to the clinic (1 April, 2005)
    M. A. Bookman
  • Gemcitabine reverses platinum resistance in platinum-resistant ovarian and peritoneal carcinoma (1 April, 2005)
    P. G. Rose
  • Review of gemcitabine-based combinations for platinum-resistant ovarian cancer (1 April, 2005)
    J. Sehouli
  • Management of platinum-sensitive relapsed ovarian cancer, with particular reference to the International Collaboration in Ovarian Neoplasm-4/Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer-2.2 trial (1 April, 2005)
    S. B. Kaye
  • Combination therapy with gemcitabine and carboplatin in recurrent ovarian cancer (1 April, 2005)
    J. Pfisterer, I. Vergote, A. Du Bois, E. Eisenhauer
  • Future options for first-line therapy of advanced ovarian cancer (1 April, 2005)
    A. Du Bois, J. Pfisterer
  • European Society of Gynaecological Oncology (ESGO)
  • International Gynecologic Cancer Society (IGCS)
  • Content
    • Latest content
    • Current issue
    • Archive
    • Browse by collection
    • Podcasts
    • Videos
    • Twitter Journal Club
  • Journal
    • About
    • Editorial board
    • Thank you to our reviewers
    • Sign up for email alerts
    • Subscribe
  • Authors
    • Instructions for authors
    • Submit an article
    • Open Access at BMJ
  • Help
    • Contact us
    • Reprints
    • Permissions
    • Advertising
    • Feedback form
  • Facebook
  • Twitter
  • Soundcloud
  • RSS
  • Website Terms & Conditions
  • Privacy & Cookies
  • Contact BMJ

Online: ISSN 1525-1438Print: ISSN 1048-891X
Copyright © 2023 BMJ Publishing Group Ltd, International Gynecologic Cancer Society, & European Society of Gynaecological Oncology. All rights reserved.